Open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with oxaliplatin and 5-fluorouracil/folinic acid followed by curative surgical resection in patients with hepatic oligometastatic adenocarcinoma of the pancreas (HOLIPANC)

Gebauer, Florian and Schmidt, Thomas and Damanakis, Alexander and Quaas, Alexander and Cay, Duygu and Kehmann, Linde and Deuss, Burkhardt and Held, Swantje and Werner, Jens and Rehders, Alexander and Schineis, Christian and Reim, Daniel and Wittel, Uwe A. and Werner, Jens and Glowka, Tim and Ronellenfitsch, Ulrich and Wiltberger, Georg and Mees, Soren T. and Bruns, Christiane J. and Waldschmidt, Dirk (2023) Open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with oxaliplatin and 5-fluorouracil/folinic acid followed by curative surgical resection in patients with hepatic oligometastatic adenocarcinoma of the pancreas (HOLIPANC). In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 02-06, 2023, Chicago, IL.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Poster)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Chirurgie
Depositing User:	Dr. Gernot Deinzer
Date Deposited:	08 Mar 2024 10:23
Last Modified:	08 Mar 2024 10:23
URI:	https://pred.uni-regensburg.de/id/eprint/60342

Actions (login required)

View Item